Crinetics Pharmaceuticals, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
1.63 |
5.14 |
45.32 |
186.28 |
527.02 |
1,172.35 |
| Przychód Δ r/r |
0.00% |
215.63% |
782.21% |
311.08% |
182.92% |
122.45% |
| Przychód (min) |
1.44 |
2.03 |
25.99 |
186.28 |
278.74 |
620.05 |
| Przychód (max) |
2.39 |
13.44 |
108.75 |
186.28 |
1,251.22 |
2,783.32 |
| EBITDA (średnia) |
-1.63 |
-5.14 |
-45.32 |
-186.28 |
-527.02 |
-1,172.35 |
| EBIT (średnia) |
-1.63 |
-5.14 |
-45.32 |
-186.28 |
-527.02 |
-1,172.35 |
| EBIT % |
-100.00% |
-100.00% |
-100.00% |
-100.00% |
-100.00% |
-100.00% |
| Zysk netto (średni) |
-303.44 |
-358.64 |
-485.59 |
-361.88 |
-76.10 |
294.53 |
| Zysk netto % |
-18645.56% |
-6982.08% |
-1071.59% |
-194.27% |
-14.44% |
25.12% |
| EPS (średnia) |
-3.69 |
-4.44 |
-4.60 |
-3.33 |
-0.94 |
3.65 |
| Liczba analityków (Przychody) |
10 |
11 |
15 |
9 |
3 |
4 |
| Liczba analityków (EPS) |
11 |
10 |
12 |
6 |
3 |
4 |
| symbol |
CRNX |
CRNX |
CRNX |
CRNX |
CRNX |
CRNX |